These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 1522231)

  • 21. Control of glomerular hypertension limits glomerular injury in rats with reduced renal mass.
    Anderson S; Meyer TW; Rennke HG; Brenner BM
    J Clin Invest; 1985 Aug; 76(2):612-9. PubMed ID: 2993362
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Angiotensin II and renal functional reserve in rats with Goldblatt hypertension.
    De Nicola L; Keiser JA; Blantz RC; Gabbai FB
    Hypertension; 1992 Jun; 19(6 Pt 2):790-4. PubMed ID: 1592482
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Haemodynamic effects of losartan and the endothelin antagonist, SB 209670, in conscious, transgenic ((mRen-2)27), hypertensive rats.
    Gardiner SM; March JE; Kemp PA; Mullins JJ; Bennett T
    Br J Pharmacol; 1995 Oct; 116(4):2237-44. PubMed ID: 8564254
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Time course of losartan blockade of angiotensin II hypertension versus blockade of angiotensin II fast pressor effects.
    Gorbea-Oppliger VJ; Melaragno MG; Potter GS; Petit RL; Fink GD
    J Pharmacol Exp Ther; 1994 Nov; 271(2):804-10. PubMed ID: 7965799
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of acute angiotensin II blockade on renal function in rats with reduced renal mass.
    Baboolal K; Meyer TW
    Kidney Int; 1994 Oct; 46(4):980-5. PubMed ID: 7861724
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of chronic inhibition of ACE and AT1 receptors on glomerular injury in dahl salt-sensitive rats.
    Otsuka F; Yamauchi T; Kataoka H; Mimura Y; Ogura T; Makino H
    Am J Physiol; 1998 Jun; 274(6):R1797-806. PubMed ID: 9841488
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The antihypertensive effect of the angiotensin II receptor antagonist DuP 753 may not be due solely to angiotensin II receptor antagonism.
    Ohlstein EH; Gellai M; Brooks DP; Vickery L; Jugus J; Sulpizio A; Ruffolo RR; Weinstock J; Edwards RM
    J Pharmacol Exp Ther; 1992 Aug; 262(2):595-601. PubMed ID: 1501114
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of angiotensin II receptor antagonism and converting enzyme inhibition in the progression and regression of cardiac hypertrophy in rats.
    Linz W; Henning R; Schölkens BA
    J Hypertens Suppl; 1991 Dec; 9(6):S400-1. PubMed ID: 1840203
    [No Abstract]   [Full Text] [Related]  

  • 29. The molecular basis of increased glomerulosclerosis after blockade of the renin angiotensin system in growth hormone transgenic mice.
    Peten EP; Striker LJ; Fogo A; Ichikawa I; Patel A; Striker GE
    Mol Med; 1994 Nov; 1(1):104-15. PubMed ID: 8790606
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antihypertensive and renal protective effects of renin-angiotensin system blockade in uremic rats treated with erythropoietin.
    Lebel M; Rodrigue ME; Agharazii M; Larivière R
    Am J Hypertens; 2006 Dec; 19(12):1286-92. PubMed ID: 17161776
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of angiotensin-converting enzyme inhibition and AT1 receptor blockade on cardiac pump performance after myocardial infarction in rats.
    Capasso JM; Li P; Meggs LG; Herman MV; Anversa P
    J Cardiovasc Pharmacol; 1994 Apr; 23(4):584-93. PubMed ID: 7516008
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Angiotensin-converting enzyme inhibitor versus angiotensin II, AT1 receptor antagonist. Effects on smooth muscle cell migration and proliferation after balloon catheter injury.
    Prescott MF; Webb RL; Reidy MA
    Am J Pathol; 1991 Dec; 139(6):1291-6. PubMed ID: 1750504
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Renal responses to acute angiotensin II inhibition and administered angiotensin II in the aging, conscious, chronically catheterized rat.
    Baylis C
    Am J Kidney Dis; 1993 Dec; 22(6):842-50. PubMed ID: 8250031
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanistic analysis of renal protection by angiotensin converting enzyme inhibitor in Dahl salt-sensitive rats.
    Hirawa N; Uehara Y; Kawabata Y; Ohshima N; Ono H; Nagata T; Gomi T; Ikeda T; Goto A; Yagi S
    J Hypertens; 1994 Aug; 12(8):909-18. PubMed ID: 7814850
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Renal effects of an angiotensin II antagonist in stroke-prone spontaneously hypertensive rat.
    Yo Y; Moriguchi A; Higaki J; Nagano M; Nakano N; Kamide K; Yu H; Mikami H; Ogihara T
    Nephron; 1997; 76(4):466-71. PubMed ID: 9274845
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential effects of oral losartan and enalapril on local venous and systemic pressor responses to angiotensin I and II in healthy men.
    Goldberg MR; de Mey C; Wroblewski JM; Li Q; Schroeter V; Belz GG
    Clin Pharmacol Ther; 1996 Jan; 59(1):72-82. PubMed ID: 8549037
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of angiotensin II blockade on dietary protein-induced renal growth.
    Smith LJ; Rosenberg ME; Hostetter TH
    Am J Kidney Dis; 1993 Jul; 22(1):120-7. PubMed ID: 8322774
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of aldosterone in the remnant kidney model in the rat.
    Greene EL; Kren S; Hostetter TH
    J Clin Invest; 1996 Aug; 98(4):1063-8. PubMed ID: 8770880
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Angiotensin II stimulation of left ventricular hypertrophy in adult rat heart. Mediation by the AT1 receptor.
    Dostal DE; Baker KM
    Am J Hypertens; 1992 May; 5(5 Pt 1):276-80. PubMed ID: 1533768
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of selective A1 receptor blockade on glomerular hemodynamics: involvement of renin-angiotensin system.
    Munger KA; Jackson EK
    Am J Physiol; 1994 Nov; 267(5 Pt 2):F783-90. PubMed ID: 7977781
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.